This invention relates to: a novel use of GST-À and GST-À suppressing agents; an apoptosis-inducing agent containing as active components a drug that suppresses GST-À and a drug that suppresses autophagy; a medical composition containing said agent; and a method using said medical composition for treating diseases associated with abnormal apoptosis.